ENTB.F logo

Entheon Biomedical OTCPK:ENTB.F Stock Report

Last Price

US$0.096

Market Cap

US$1.0m

7D

-16.7%

1Y

39.0%

Updated

23 Dec, 2024

Data

Company Financials

Entheon Biomedical Corp.

OTCPK:ENTB.F Stock Report

Market Cap: US$1.0m

My Notes

Capture your thoughts, links and company narrative

Entheon Biomedical Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Entheon Biomedical
Historical stock prices
Current Share PriceCA$0.096
52 Week HighCA$0.20
52 Week LowCA$0.022
Beta1.25
1 Month Change3.68%
3 Month Change73.42%
1 Year Change38.99%
3 Year Change-96.62%
5 Year Changen/a
Change since IPO-97.55%

Recent News & Updates

Recent updates

Shareholder Returns

ENTB.FUS BiotechsUS Market
7D-16.7%-3.8%-2.7%
1Y39.0%-2.6%23.4%

Return vs Industry: ENTB.F exceeded the US Biotechs industry which returned -2.6% over the past year.

Return vs Market: ENTB.F exceeded the US Market which returned 23.4% over the past year.

Price Volatility

Is ENTB.F's price volatile compared to industry and market?
ENTB.F volatility
ENTB.F Average Weekly Movement87.3%
Biotechs Industry Average Movement10.7%
Market Average Movement6.3%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: ENTB.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: ENTB.F's weekly volatility has decreased from 101% to 87% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a1Timothy Kowww.entheonbiomedical.com

Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada.

Entheon Biomedical Corp. Fundamentals Summary

How do Entheon Biomedical's earnings and revenue compare to its market cap?
ENTB.F fundamental statistics
Market capUS$1.05m
Earnings (TTM)-US$214.11k
Revenue (TTM)n/a

0.0x

P/S Ratio

-4.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ENTB.F income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$307.69k
Earnings-CA$307.69k

Last Reported Earnings

Aug 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.035
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did ENTB.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:19
End of Day Share Price 2024/12/20 00:00
Earnings2024/08/31
Annual Earnings2023/11/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Entheon Biomedical Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution